Loading
CM
Cannvas MedTech Inc. Stock: price and insider trades · Canada
Cannvas MedTech Inc.: what insiders have been doing
Cannvas MedTech Inc. is a listed company. Its directors and officers file their transactions with SEDI. Cannvas MedTech Inc. has had no insider filing for more than a year; the last one goes back to 8 August 2019.
The full history, which starts in 2018, counts 126 purchases against no sales.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
159
Thresholds
n/a
Buy Volume
€317,049
126 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 8 August 2019
Declarations159 total
1,450,000 shares@ CA$0.2343.9% of flowCommon SharesTSXSEDI:3407265
1,450,000 shares@ CA$0.2334.5% of flowCommon SharesTSXSEDI:3407263
Common SharesTSXSEDI:3407264
Common SharesTSXSEDI:3407249
10,000 shares@ CA$0.28130.1% of flowCommon SharesTSXSEDI:3401685
Canonical exit: 8 Aug 2019 (T+90)
15,000 shares@ CA$0.24780.1% of flowCommon SharesTSXSEDI:3401684
Canonical exit: 28 Jul 2019 (T+90)
100,000 shares@ CA$0.24861.0% of flowCommon SharesTSXSEDI:3401686
Canonical exit: 29 Aug 2019 (T+90)
49,000 shares@ CA$0.25140.5% of flowCommon SharesTSXSEDI:3401692
Canonical exit: 26 May 2019 (T+90)
105,000 shares@ CA$0.24011.0% of flowCommon SharesTSXSEDI:3401683
Canonical exit: 23 Jul 2019 (T+90)
42,000 shares@ CA$0.21440.4% of flowCommon SharesTSXSEDI:3401688
Canonical exit: 19 Sept 2019 (T+90)
90,000 shares@ CA$0.24050.9% of flowCommon SharesTSXSEDI:3401687
Canonical exit: 12 Sept 2019 (T+90)
122,500 shares@ CA$0.17960.9% of flowCommon SharesTSXSEDI:3401693
Canonical exit: 11 Jul 2019 (T+90)
10,000 shares@ CA$0.2250.1% of flowCommon SharesTSXSEDI:3401691
Canonical exit: 1 Oct 2019 (T+90)
4,500 shares@ CA$0.25110.0% of flowCommon SharesTSXSEDI:3401682
Canonical exit: 2 Jun 2019 (T+90)
84,500 shares@ CA$0.20810.7% of flowCommon SharesTSXSEDI:3401689
Canonical exit: 25 Sept 2019 (T+90)
6,500 shares@ CA$0.2450.1% of flowCommon SharesTSXSEDI:3401681
Canonical exit: 27 May 2019 (T+90)
10,000 shares@ CA$0.22250.1% of flowCommon SharesTSXSEDI:3401690
Canonical exit: 26 Sept 2019 (T+90)
59,000 shares@ CA$0.2590.6% of flowCommon SharesTSXSEDI:3401678
Canonical exit: 20 May 2019 (T+90)
688,801 sharesCommon SharesTSXSEDI:3401676
1,491,925 shares@ CA$0.2013.4% of flowCommon SharesTSXSEDI:3399502
1,491,925 shares@ CA$0.2011.9% of flowCommon SharesTSXSEDI:3399493
125,000 shares@ CA$0.201.0% of flowCommon SharesTSXSEDI:3399497
125,000 shares@ CA$0.201.1% of flowCommon SharesTSXSEDI:3399507
25,000 shares@ CA$0.2010.1% of flowCommon SharesTSXSEDI:3399512
8,000 shares@ CA$0.270.1% of flowCommon SharesTSXSEDI:3317127
Canonical exit: 15 May 2019 (T+90)
25 of 159 declarations
About Cannvas MedTech Inc.
Cannvas MedTech Inc. is a Canadian company focused on developing technology solutions for the cannabis sector. It aims to educate and engage consumers through digital platforms.
